CIBC WORLD MARKET INC. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
CIBC WORLD MARKET INC. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$11,208
-14.9%
116,280
-10.9%
0.04%
-11.9%
Q2 2023$13,174
+10.2%
130,550
+0.5%
0.04%
+5.0%
Q1 2023$11,954
+0.1%
129,936
-1.2%
0.04%
-4.8%
Q4 2022$11,937
-99.9%
131,578
+0.0%
0.04%
+10.5%
Q3 2022$9,997,000
-12.6%
131,524
-2.8%
0.04%
-5.0%
Q2 2022$11,443,000
-4.5%
135,376
-0.9%
0.04%
+5.3%
Q1 2022$11,983,000
-7.8%
136,564
-8.1%
0.04%
+2.7%
Q4 2021$13,003,000
+7.1%
148,657
+0.2%
0.04%
-7.5%
Q3 2021$12,138,000
-10.9%
148,420
-0.6%
0.04%
+5.3%
Q2 2021$13,626,000
+10.4%
149,338
+3.4%
0.04%
+5.6%
Q1 2021$12,340,000
-6.8%
144,363
+2.9%
0.04%
-14.3%
Q4 2020$13,245,000
+28.2%
140,267
+18.1%
0.04%
-6.7%
Q3 2020$10,331,000
+7.3%
118,797
+7.7%
0.04%
+2.3%
Q2 2020$9,630,000
+10.4%
110,259
+4.2%
0.04%
-2.2%
Q1 2020$8,722,000
+28.6%
105,786
+47.7%
0.04%
+60.7%
Q4 2019$6,781,000
+14.2%
71,613
+4.8%
0.03%
+3.7%
Q3 2019$5,936,000
-3.4%
68,314
+1.5%
0.03%0.0%
Q2 2019$6,144,000
+13.9%
67,292
+5.5%
0.03%
+8.0%
Q1 2019$5,394,000
-41.5%
63,779
-40.7%
0.02%
-46.8%
Q4 2018$9,223,000
-2.1%
107,481
-1.7%
0.05%
+17.5%
Q3 2018$9,418,000
+12.6%
109,305
-1.3%
0.04%
+8.1%
Q2 2018$8,365,000
+17.2%
110,738
+25.5%
0.04%
+27.6%
Q1 2018$7,135,000
+151.9%
88,253
+161.6%
0.03%
+123.1%
Q4 2017$2,833,000
+18.6%
33,741
+21.3%
0.01%
+18.2%
Q3 2017$2,388,000
-72.4%
27,818
-73.1%
0.01%
-70.3%
Q2 2017$8,644,000
+91.2%
103,556
+70.1%
0.04%
+146.7%
Q1 2017$4,522,000
-34.6%
60,880
-35.9%
0.02%
-42.3%
Q4 2016$6,917,000
+62.3%
94,960
+75.9%
0.03%
+52.9%
Q3 2016$4,263,000
+29.8%
53,989
+35.6%
0.02%
+21.4%
Q2 2016$3,285,000
+205.3%
39,815
+168.1%
0.01%
+180.0%
Q1 2016$1,076,000
-49.1%
14,851
-39.5%
0.01%
-54.5%
Q4 2015$2,112,000
+26.2%
24,550
+34.9%
0.01%
+37.5%
Q3 2015$1,673,000
-23.8%
18,205
-18.4%
0.01%
-20.0%
Q2 2015$2,195,000
+34.3%
22,321
+34.6%
0.01%
+42.9%
Q1 2015$1,635,000
+220.0%
16,584
+200.8%
0.01%
+250.0%
Q4 2014$511,000
-2.7%
5,514
-1.2%
0.00%0.0%
Q3 2014$525,000
+43.8%
5,582
+38.3%
0.00%
+100.0%
Q2 2014$365,000
+8.0%
4,037
+1.5%
0.00%0.0%
Q1 2014$338,000
+4.6%
3,977
-1.0%
0.00%0.0%
Q4 2013$323,000
+12.9%
4,016
+7.8%
0.00%0.0%
Q3 2013$286,000
+38.8%
3,725
+27.9%
0.00%0.0%
Q2 2013$206,0002,9120.00%
Other shareholders
NOVARTIS A G shareholders Q1 2023
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders